CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

OptimizeRx (OPRX) Financial Analysis | CapyFin

OptimizeRx

OPRX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 26 days ago

Previous year: $32.3M

Previous year: $0.3

Avg Revenue Top 20 Pharma

Previous year: $2.98M

Top 20 Pharma Revenue %

Previous year: 65%

Net Revenue Retention

Previous year: 121%

Previous year: $22M

Cash and Equivalents

Previous year: $13.4M

Previous year: $4.89M

Previous year: $171M

Loading...

OptimizeRx

Unlock previous datapoints

OptimizeRx

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$124M

P/E Ratio

6.27

Sector

N/A

Industry

N/A

52-Week High

$21.6

52-Week Low

$5.92

Avg Revenue Top 20 Pharma

$2.84M

Top 20 Pharma Revenue %

52%

Net Revenue Retention

116%

Revenue per Employee

$839K

Adjusted EBITDA

$12M